tiprankstipranks
Edwards Lifesciences Corp. (MX:EW)
NYSE:EW
Mexico Market
EW
Edwards Lifesciences
RESEARCH TOOLSreports

Edwards Lifesciences (EW) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

EW Analyst Ratings

Strong Buy
18Ratings
Strong Buy
15 Buy
3 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Edwards
Lifesciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EW Stock 12 Month Forecast

Average Price Target

$1,792.91
Based on 18 Wall Street analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is $1,792.91 with a high forecast of $1,925.97 and a low forecast of $1,488.25. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1364":"$1,364","1645":"$1,645","1926":"$1,926","1504.5":"$1,504.5","1785.5":"$1,785.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1925.9726167,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.93K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1792.9054177280002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.79K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1488.25156745,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.49K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1364,1504.5,1645,1785.5,1926],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1518.55,1549.8902012846154,1581.2304025692308,1612.570603853846,1643.9108051384615,1675.251006423077,1706.5912077076923,1737.9314089923075,1769.271610276923,1800.6118115615384,1831.9520128461538,1863.292214130769,1894.6324154153845,{"y":1925.9726167,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1518.55,1539.6542629021537,1560.7585258043077,1581.8627887064615,1602.9670516086155,1624.0713145107693,1645.175577412923,1666.279840315077,1687.3841032172309,1708.4883661193849,1729.5926290215386,1750.6968919236924,1771.8011548258464,{"y":1792.9054177280002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1518.55,1516.2193513423076,1513.8887026846153,1511.558054026923,1509.2274053692308,1506.8967567115385,1504.5661080538462,1502.2354593961538,1499.9048107384615,1497.5741620807692,1495.243513423077,1492.9128647653847,1490.5822161076924,{"y":1488.25156745,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1456,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1525.23,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1525.23,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1372,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1372,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1585.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1562.05,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1397.53,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1365.23,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1474.23,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1427,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1501,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1518.55,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,926Average Price Target$1,793Lowest Price Target$1,488
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on MX:EW
Adam Maeder
Piper Sandler
Piper Sandler
$1,750.88→$1,768.39
Buy
―
Reiterated
07/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (NYSE: EW), Atricure (NASDAQ: ATRC) and Medpace Holdings (NASDAQ: MEDP)
Oppenheimer Analyst forecast on MX:EW
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY) and Edwards Lifesciences (NYSE: EW)
Leerink Partners Analyst forecast on MX:EW
Mike Kratky
Leerink Partners
Leerink Partners
$1,523.27→$1,768.39
Buy
―
Upgraded
07/24/26
Edwards Lifesciences upgraded to Outperform from Market Perform at LeerinkEdwards Lifesciences upgraded to Outperform from Market Perform at Leerink
J.P. Morgan Analyst forecast on MX:EW
Robbie Marcus
J.P. Morgan
J.P. Morgan
$1,750.88→$1,838.43
Buy
―
Reiterated
07/24/26
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Edwards Lifesciences (EW)
Truist Financial Analyst forecast on MX:EW
Richard Newitter
Truist Financial
Truist Financial
$1,663.34
Hold
―
Reiterated
07/24/26
Analysts Are Neutral on These Healthcare Stocks: DENTSPLY SIRONA (XRAY), Edwards Lifesciences (EW)
Stifel Nicolaus Analyst forecast on MX:EW
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$1,925.97
Buy
―
Reiterated
07/24/26
Stifel Nicolaus Keeps Their Buy Rating on Edwards Lifesciences (EW)
William Blair Analyst forecast on MX:EW
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
07/24/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Atricure (ATRC)
BTIG Analyst forecast on MX:EW
Marie Thibault
BTIG
BTIG
$1,925.97
Buy
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
TD Cowen Analyst forecast on MX:EW
Josh Jennings
TD Cowen
TD Cowen
$1,820.92
Buy
―
Assigned
07/23/26
Edwards Lifesciences: Buy Rating Reaffirmed as Analyst Lifts Price Target from $85 to $104 on TAVR Momentum and TMTT Catalysts
Canaccord Genuity Analyst forecast on MX:EW
William Plovanic
Canaccord Genuity
Canaccord Genuity
$1,488.25
Hold
―
Reiterated
07/23/26
Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts
RBC Capital Analyst forecast on MX:EW
Shagun Singh Chadha
RBC Capital
RBC Capital
$1,925.97
Buy
―
Reiterated
07/23/26
RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW)
Bank of America Securities Analyst forecast on MX:EW
Travis Steed
Bank of America Securities
Bank of America Securities
$1,750.88
Buy
―
Reiterated
07/21/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Arcus Biosciences (RCUS)
Mizuho Securities Analyst forecast on MX:EW
Anthony Petrone
Mizuho Securities
Mizuho Securities
$1,750.88→$1,838.43
Buy
―
Reiterated
07/15/26
Edwards Lifesciences price target raised to $105 from $100 at MizuhoEdwards Lifesciences price target raised to $105 from $100 at Mizuho
Citi Analyst forecast on MX:EW
Joanne Wuensch
Citi
Citi
$1,768.39→$1,925.97
Buy
―
Reiterated
07/08/26
Citi Keeps Their Buy Rating on Edwards Lifesciences (EW)
Evercore ISI Analyst forecast on MX:EW
Vijay Kumar
Evercore ISI
Evercore ISI
$1,628.32→$1,750.88
Buy
―
Reiterated
07/06/26
Edwards Lifesciences price target raised to $100 from $93 at Evercore ISIEdwards Lifesciences price target raised to $100 from $93 at Evercore ISI
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on MX:EW
Adam Maeder
Piper Sandler
Piper Sandler
$1,750.88→$1,768.39
Buy
―
Reiterated
07/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (NYSE: EW), Atricure (NASDAQ: ATRC) and Medpace Holdings (NASDAQ: MEDP)
Oppenheimer Analyst forecast on MX:EW
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY) and Edwards Lifesciences (NYSE: EW)
Leerink Partners Analyst forecast on MX:EW
Mike Kratky
Leerink Partners
Leerink Partners
$1,523.27→$1,768.39
Buy
―
Upgraded
07/24/26
Edwards Lifesciences upgraded to Outperform from Market Perform at LeerinkEdwards Lifesciences upgraded to Outperform from Market Perform at Leerink
J.P. Morgan Analyst forecast on MX:EW
Robbie Marcus
J.P. Morgan
J.P. Morgan
$1,750.88→$1,838.43
Buy
―
Reiterated
07/24/26
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Edwards Lifesciences (EW)
Truist Financial Analyst forecast on MX:EW
Richard Newitter
Truist Financial
Truist Financial
$1,663.34
Hold
―
Reiterated
07/24/26
Analysts Are Neutral on These Healthcare Stocks: DENTSPLY SIRONA (XRAY), Edwards Lifesciences (EW)
Stifel Nicolaus Analyst forecast on MX:EW
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$1,925.97
Buy
―
Reiterated
07/24/26
Stifel Nicolaus Keeps Their Buy Rating on Edwards Lifesciences (EW)
William Blair Analyst forecast on MX:EW
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
07/24/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Atricure (ATRC)
BTIG Analyst forecast on MX:EW
Marie Thibault
BTIG
BTIG
$1,925.97
Buy
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
TD Cowen Analyst forecast on MX:EW
Josh Jennings
TD Cowen
TD Cowen
$1,820.92
Buy
―
Assigned
07/23/26
Edwards Lifesciences: Buy Rating Reaffirmed as Analyst Lifts Price Target from $85 to $104 on TAVR Momentum and TMTT Catalysts
Canaccord Genuity Analyst forecast on MX:EW
William Plovanic
Canaccord Genuity
Canaccord Genuity
$1,488.25
Hold
―
Reiterated
07/23/26
Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts
RBC Capital Analyst forecast on MX:EW
Shagun Singh Chadha
RBC Capital
RBC Capital
$1,925.97
Buy
―
Reiterated
07/23/26
RBC Capital Keeps Their Buy Rating on Edwards Lifesciences (EW)
Bank of America Securities Analyst forecast on MX:EW
Travis Steed
Bank of America Securities
Bank of America Securities
$1,750.88
Buy
―
Reiterated
07/21/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Arcus Biosciences (RCUS)
Mizuho Securities Analyst forecast on MX:EW
Anthony Petrone
Mizuho Securities
Mizuho Securities
$1,750.88→$1,838.43
Buy
―
Reiterated
07/15/26
Edwards Lifesciences price target raised to $105 from $100 at MizuhoEdwards Lifesciences price target raised to $105 from $100 at Mizuho
Citi Analyst forecast on MX:EW
Joanne Wuensch
Citi
Citi
$1,768.39→$1,925.97
Buy
―
Reiterated
07/08/26
Citi Keeps Their Buy Rating on Edwards Lifesciences (EW)
Evercore ISI Analyst forecast on MX:EW
Vijay Kumar
Evercore ISI
Evercore ISI
$1,628.32→$1,750.88
Buy
―
Reiterated
07/06/26
Edwards Lifesciences price target raised to $100 from $93 at Evercore ISIEdwards Lifesciences price target raised to $100 from $93 at Evercore ISI
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Edwards Lifesciences

3 Months
Adam MaederPiper Sandler
Success Rate
17/27 ratings generated profit
63%
Average Return
+1.13%
Copying Adam Maeder's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +1.13% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
18/25 ratings generated profit
72%
Average Return
+11.57%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +11.57% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
16/25 ratings generated profit
64%
Average Return
+16.60%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 64.00% of your transactions generating a profit, with an average return of +16.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EW Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
36
35
30
40
37
Hold
11
11
3
5
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
47
46
33
45
43
In the current month, EW has received 37 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. EW average Analyst price target in the past 3 months is 1,792.91.
Each month's total comprises the sum of three months' worth of ratings.

EW Financial Forecast

EW Earnings Forecast

Next quarter’s earnings estimate for EW is $12.90 with a range of $12.55 to $13.44. The previous quarter’s EPS was $13.60. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 48.00% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s earnings estimate for EW is $12.90 with a range of $12.55 to $13.44. The previous quarter’s EPS was $13.60. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 48.00% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Sales Forecast

Next quarter’s sales forecast for EW is $29.22B with a range of $28.77B to $29.81B. The previous quarter’s sales results were $30.35B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 55.41% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s sales forecast for EW is $29.22B with a range of $28.77B to $29.81B. The previous quarter’s sales results were $30.35B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 55.41% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Stock Forecast FAQ

What is MX:EW’s average 12-month price target, according to analysts?
Based on analyst ratings, Edwards Lifesciences Corp.’s 12-month average price target is 1,792.91.
    What is MX:EW’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:EW, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Edwards Lifesciences Corp. a Buy, Sell or Hold?
        Edwards Lifesciences Corp. has a consensus rating of Strong Buy, which is based on 15 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Edwards Lifesciences Corp.’s share price target?
          The average share price target for Edwards Lifesciences Corp. is 1,792.91. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $1,925.97 ,and the lowest forecast is $1,488.25. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Edwards Lifesciences Corp.?
            Edwards Lifesciences Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
              How can I buy shares of Edwards Lifesciences Corp.?
              To buy shares of MX:EW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.